scholarly article | Q13442814 |
P50 | author | R. J. Berry | Q7273706 |
P2093 | author name string | Li S | |
Wang H | |||
Li Z | |||
Zhao P | |||
Moore CA | |||
Correa A | |||
Erickson JD | |||
Gindler J | |||
Hong SX | |||
Mulinare J | |||
Wong LY | |||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | People's Republic of China | Q148 |
collaboration | Q1145523 | ||
folic acid | Q127060 | ||
neural tube defect | Q548213 | ||
P304 | page(s) | 1485-1490 | |
P577 | publication date | 1999-11-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention | |
P478 | volume | 341 |
Q64077100 | 2-Deoxyglucose-Modified Folate Derivative: Self-Assembling Nanoparticle Able to Load Cisplatin |
Q43924093 | 2012 Update on global prevention of folic acid-preventable spina bifida and anencephaly |
Q30061994 | A 2015 global update on folic acid-preventable spina bifida and anencephaly |
Q36068204 | A Study on The Incidence of Neural Tube Defects in A Tertiary Care Hospital Over A Period of Five Years |
Q24803710 | A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects |
Q50663427 | A critical role of noggin in developing folate-nonresponsive NTD in Fkbp8 -/- embryos. |
Q46350367 | A global view of advancing neonatal health and survival |
Q24598013 | A known functional polymorphism (Ile120Val) of the human PCMT1 gene and risk of spina bifida |
Q41549089 | A missense mutation in TCN2 is associated with decreased risk for congenital heart defects and may increase cellular uptake of vitamin B12 via Megalin |
Q55260761 | A national estimate of the birth prevalence of congenital anomalies in India: systematic review and meta-analysis. |
Q47786384 | A population-based birth defects surveillance system in the People's Republic of China |
Q40488340 | A population-based case-control study of risk factors for neural tube defects in four high-prevalence areas of Shanxi province, China |
Q64115694 | A propensity-matched study of the association between optimal folic acid supplementation and birth defects in Shaanxi province, Northwestern China |
Q45007192 | A resolution on folic acid fortification |
Q38583096 | A review of European guidelines on periconceptional folic acid supplementation |
Q35309295 | A review of the social, psychological, and economic burdens experienced by people with spina bifida and their caregivers |
Q43587195 | A screen for mutations in human homologues of mice exencephaly genes Tfap2alpha and Msx2 in patients with neural tube defects. |
Q34707252 | A still born baby with cranial vault defects |
Q47271549 | Acculturation factors are associated with folate intakes among Mexican American women |
Q36538527 | Acquired and inherited disorders of cobalamin and folate in children |
Q37978356 | Adding folate to the contraceptive pill: a new concept for the prevention of neural tube defects |
Q51750316 | An exceptionally low percentage of Thai expectant mothers and medical personnel with folic acid knowledge and peri-conceptional consumption urges an urgent education program and/or food fortification. |
Q36152734 | An exploration of health effects of folic acid in pregnancy beyond reducing neural tube defects |
Q79274572 | Antagonism of Hypervitaminosis A-Induced Anterior Neural Tube Closure Defects with a Methyl-Donor Deficiency in Murine Whole-Embryo Culture |
Q35585955 | Assessing the association between natural food folate intake and blood folate concentrations: a systematic review and Bayesian meta-analysis of trials and observational studies |
Q40381589 | Assessing the case for mandatory folate fortification: policy-making in the face of scientific uncertainties |
Q35759231 | Assessing the prevalence of spina bifida and encephalocele in a Kenyan hospital from 2005-2010: implications for a neural tube defects surveillance system |
Q33480314 | Assessment of dietary intake among pregnant women in a rural area of western China |
Q40290701 | Assessment of the potential effect of incremental increases in folic acid intake on neural tube defects in Australia and New Zealand. |
Q57468876 | Association Between Maternal Serum Folate Concentrations in the First Trimester and the Risk of Birth Defects: The Hokkaido Study of Environment and Children's Health |
Q54213759 | Association analysis between MTHFR genetic polymorphisms and the risk of congenital heart diseases in Chinese Han population. |
Q40844790 | Association between ALDH1L1 gene polymorphism and neural tube defects in the Chinese Han population |
Q33277957 | Association between CFL1 gene polymorphisms and spina bifida risk in a California population |
Q35586626 | Association between MTHFR C677T polymorphism and neural tube defect risks: A comprehensive evaluation in three groups of NTD patients, mothers, and fathers |
Q34415152 | Association between MTHFR gene polymorphism and NTDs in Chinese Han population. |
Q35057390 | Association between PKA gene polymorphism and NTDs in high risk Chinese population in Shanxi |
Q35108265 | Association between inhibited binding of folic acid to folate receptor alpha in maternal serum and folate-related birth defects in Norway. |
Q44990623 | Association between maternal COMT gene polymorphisms and fetal neural tube defects risk in a Chinese population |
Q34035552 | Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children |
Q34631779 | Association between selected folate pathway polymorphisms and nonsyndromic limb reduction defects: a case-parental analysis |
Q36952737 | Association of Clomiphene and Assisted Reproductive Technologies With the Risk of Neural Tube Defects |
Q51739924 | Association of education and the occurrence of low birthweight in rural southern China during the early and late 1990s. |
Q44264110 | Association of neural tube defects and folic acid food fortification in Canada |
Q39481020 | Association of sociodemographic and nutritional factors with risk of neural tube defects in the North Indian population: a case-control study |
Q42692700 | Audit of prenatal and postnatal diagnosis of isolated open spina bifida in three university hospitals in The Netherlands. |
Q87304795 | Authors' reply to Smith and colleagues |
Q37721045 | Autoantibodies to folate receptor during pregnancy and neural tube defect risk |
Q39957952 | Awareness and Use of Folic Acid Among Pregnant Women in Taipei |
Q93051726 | Awareness and Use of Folic Acid among Women of Childbearing Age |
Q53161105 | Awareness and intake of folic acid for the prevention of neural tube defects among Lebanese women of childbearing age. |
Q41723476 | Awareness of folic acid use increases its consumption, and reduces the risk of spina bifida |
Q46383625 | Awareness of the role of folic acid, dietary folate intake and plasma folate concentration in Japan |
Q47855645 | Bayesian small area cluster analysis of neural tube defects in Newfoundland. |
Q33358977 | Bigger babies born to women survivors of the 1959-1961 Chinese famine: a puzzle due to survival selection? |
Q79274638 | Bioaccessibility of Folic Acid and (6S)-5-Methyltetrahydrofolate Decreases after the Addition of Folate-Binding Protein to Yogurt as Studied in a Dynamic In Vitro Gastrointestinal Model |
Q26785463 | Biomarkers of Nutrition for Development-Folate Review |
Q34462502 | Birth defects data from surveillance hospitals in hubei province, china, 200l - 2008 |
Q35888094 | Blood folate concentrations among women of childbearing age by race/ethnicity and acculturation, NHANES 2001-2010. |
Q30386383 | Building capacity for birth defects surveillance in Africa: Implementation of an intermediate birth defects surveillance workshop |
Q39240613 | C677T mutation in methylenetetrahydrofolate reductase gene and neural tube defects: should Japanese women undergo gene screening before pregnancy? |
Q21245277 | CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population |
Q43983018 | Caesarean delivery, caesarean delivery on maternal request and childhood overweight: a Chinese birth cohort study of 181 380 children |
Q92101974 | Cannabis Consumption Patterns Explain the East-West Gradient in Canadian Neural Tube Defect Incidence: An Ecological Study |
Q43412530 | Central nervous system congenital malformations in a developing country: issues and challenges against their prevention |
Q35894122 | Challenges in Studying Modifiable Risk Factors for Birth Defects |
Q50661403 | Changes in folic acid supplementation behaviour among women of reproductive age after the implementation of a massive supplementation programme in China. |
Q40482536 | Changes in knowledge and attitudes of folate, and use of dietary supplements among women of reproductive age in Norway 1998-2000. |
Q35687719 | Changes in the Incidence of Congenital Anomalies in Henan Province, China, from 1997 to 2011 |
Q34140955 | Children with Spina Bifida: Key Clinical Issues |
Q34045039 | Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecology |
Q52766092 | Clinical and molecular genetic characterization of two siblings with trisomy 2p24.3-pter and monosomy 5p14.3-pter. |
Q36693426 | Cognition and behavioural development in early childhood: the role of birth weight and postnatal growth |
Q40430645 | Cohort profile: The Jiaxing Birth Cohort in China |
Q39791016 | Comparison of blood folate levels among pregnant Chinese women in areas with high and low prevalence of neural tube defects |
Q38062561 | Comprehensive evaluation of Safyral(®) 2012. |
Q51759210 | Congenital abnormalities in newborns of women with pregestational diabetes: A time-trend analysis, 1994 to 2009. |
Q36595615 | Congenital malformations in Lubumbashi (Democratic Republic of Congo): about 72 cases observed and advocacy for the development of a National Registry of Congenital Malformations and a National Reference Center for Human Genetics |
Q46902448 | Consumer preferences for micronutrient strategies in China. A comparison between folic acid supplementation and folate biofortification |
Q28083544 | Contemporary issues surrounding folic Acid fortification initiatives |
Q34149295 | Contemporary management of epilepsy in pregnancy |
Q46596794 | Correlation between birth defects and dietary nutrition status in a high incidence area of China |
Q57668478 | Cranial neural tube defect after trimethoprim exposure |
Q39634211 | Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México. |
Q84066438 | Decreased incidence of myelomeningocele at birth: effect of folic acid recommendations or prenatal diagnostics? |
Q44143241 | Decreasing prevalence of neural tube defects in Utah, 1985-2000. |
Q64125511 | Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation |
Q103825196 | Demographic variations and temporal trends in prenatal use of multiple micronutrient supplements in Beijing, 2013-2017 |
Q44959949 | Describing a folic acid intervention for health care providers: implications for professional practice and continuing education |
Q26750401 | Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review |
Q41099350 | Descriptive study on neural tube defects in Argentina |
Q45985511 | Determinants of folic acid use in a multi-ethnic population of pregnant women: a cross-sectional study. |
Q37609470 | Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies. |
Q44311996 | Diet quality and risk of neural tube defects |
Q44026249 | Dietary intake and blood folate levels in Honduran women of childbearing age. |
Q36934490 | Do Biochemical Markers and Apa I Polymorphism in IGF-II Gene Play a Role in the Association of Birth Weight and Later BMI? |
Q35597656 | Do multivitamin supplements reduce the risk for congenital heart defects? Evidence and gaps |
Q47700096 | Does obesity modify the association of supplemental folic acid with folate status among nonpregnant women of childbearing age in the United States? |
Q30455344 | EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation |
Q39083739 | Early life exposure to the 1959-1961 Chinese famine has long-term health consequences |
Q35402500 | Economic burden of neural tube defects and impact of prevention with folic acid: a literature review |
Q42165039 | Effect of different dosage and administration schedules of folic acid on blood folate levels in a population of Honduran women of reproductive age. |
Q38727490 | Effect of folic acid supplementation on oxidative gastric mucosa damage and acid secretory response in the rat. |
Q89581497 | Effect of once weekly folic acid supplementation on erythrocyte folate concentrations in women to determine potential to prevent neural tube defects: a randomised controlled dose-finding trial in Malaysia |
Q36732102 | Effectiveness of Folic Acid Fortified Flour for Prevention of Neural Tube Defects in a High Risk Region. |
Q24234551 | Effects and safety of periconceptional folate supplementation for preventing birth defects |
Q24187120 | Effects and safety of periconceptional oral folate supplementation for preventing birth defects |
Q41177856 | Effects of 6-Month Folic Acid Supplementation on Cognitive Function and Blood Biomarkers in Mild Cognitive Impairment: A Randomized Controlled Trial in China |
Q89943862 | Effects of Preconception Care and Periconception Interventions on Maternal Nutritional Status and Birth Outcomes in Low- and Middle-Income Countries: A Systematic Review |
Q47285255 | Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trail |
Q30586300 | Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals |
Q73082976 | Effects of food supplementation and education on folate stores |
Q44777677 | Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women |
Q34769390 | Elevated levels of protein in urine in adulthood after exposure to the Chinese famine of 1959-61 during gestation and the early postnatal period |
Q45014382 | Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. |
Q34154450 | Environmental alterations of epigenetics prior to the birth |
Q35904831 | Epidemiology of Birth Defects Based on a Birth Defect Surveillance System from 2005 to 2014 in Hunan Province, China |
Q24797896 | Epidemiology of neural tube defects and folic acid |
Q36819836 | Epidemiology of the neural tube defects in Kashmir Valley |
Q40470786 | Epidemiology of the neural tube defects in Kashmir Valley. |
Q40093386 | Epidemiology of twin births in southeast China: 1993-2005. |
Q35183494 | Epidemiology, prenatal management, and prevention of neural tube defects. |
Q35048887 | Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop |
Q34183395 | Erythrocyte folate concentrations, CpG methylation at genomically imprinted domains, and birth weight in a multiethnic newborn cohort |
Q42164854 | Erythrocyte folate, plasma folate and plasma homocysteine during normal pregnancy and postpartum: a longitudinal study comprising 404 Danish women |
Q37246188 | Establishing safe and potentially efficacious fortification contents for folic acid and vitamin B12. |
Q42751608 | Evaluation of calcium and folic acid supplementation in prenatal care in São Paulo |
Q34362719 | Evaluation of common genetic variants in 82 candidate genes as risk factors for neural tube defects |
Q43799297 | Evaluation of the significance of dietary folate from wild vegetables in Vietnam |
Q47752429 | Evidence for potential underestimation of clinical folate deficiency in resource-limited countries using blood tests |
Q35754318 | Evidence for suboptimal use of periconceptional folic acid supplements globally |
Q33608040 | Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations |
Q35879862 | Extramural prevention research at the Centers for Disease Control and Prevention |
Q34317283 | Factors associated with prenatal folic acid and iron supplementation among 21,889 pregnant women in Northern Tanzania: a cross-sectional hospital-based study |
Q35773215 | Factors contributing to the success of folic acid public health campaigns |
Q51822259 | Fetal macrosomia and adolescence obesity: results from a longitudinal cohort study. |
Q34585150 | Fetal pharmacotherapy |
Q52578173 | Folate Nutrition Status in Mothers of the Boston Birth Cohort, Sample of a US Urban Low-Income Population. |
Q92189183 | Folate Status and Neural Tube Defects in Aboriginal Australians: the Success of Mandatory Fortification in Reducing a Health Disparity |
Q26852086 | Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role |
Q38540574 | Folate and Vitamin B12 Status in Latin America and the Caribbean: An Update. |
Q33442336 | Folate and homocysteine phenotypes: Comparative findings using research and clinical laboratory data |
Q46407725 | Folate and vitamin B12 status of women of reproductive age living in Hanoi City and Hai Duong Province of Vietnam |
Q33790582 | Folate bioavailability: implications for establishing dietary recommendations and optimizing status |
Q44389640 | Folate content and composition of vegetables commonly consumed in China. |
Q28302935 | Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects |
Q33558438 | Folate deficiency facilitates recruitment of upstream binding factor to hot spots of DNA double-strand breaks of rRNA genes and promotes its transcription |
Q43723743 | Folate fortification: potential impact on folate intake in an older population |
Q50726032 | Folate intakes and folate biomarker profiles of pregnant Japanese women in the first trimester. |
Q39409120 | Folate intakes from diet and supplements may place certain Canadians at risk for folic acid toxicity |
Q47594484 | Folate status in women of reproductive age as basis of neural tube defect risk assessment |
Q35671164 | Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 µg and 400 µg per day. |
Q24187457 | Folate supplementation in women of reproductive age |
Q56353720 | Folate supplementation to prevent birth abnormalities: evaluating a community-based participatory action plan for refugees and migrant workers on the Thailand-Myanmar border |
Q35806733 | Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies |
Q50216054 | Folate, vitamin B12, homocysteine and polymorphisms in folate metabolizing genes in children with congenital heart disease and their mothers |
Q44920253 | Folate-regulated changes in gene expression in the anterior neural tube of folate binding protein-1 (Folbp1)-deficient murine embryos |
Q37009939 | Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial |
Q57707159 | Folic Acid Supplementation and Interpregnancy Interval |
Q35688099 | Folic Acid Supplementation for Women of Childbearing Age versus Supplementation for the General Population: A Review of the Known Advantages and Risks |
Q42942499 | Folic acid and birth malformations. |
Q35244421 | Folic acid and human reproduction-ten important issues for clinicians |
Q34068983 | Folic acid and orofacial clefts: a review of the evidence |
Q37962225 | Folic acid and other potential measures in the prevention of neural tube defects |
Q43845574 | Folic acid consumption throughout pregnancy: differentiation between trimesters |
Q39381004 | Folic acid deficiency inhibits neural rosette formation and neuronal differentiation from rhesus monkey embryonic stem cells. |
Q37246181 | Folic acid for the prevention of neural tube defects: the Danish experience |
Q42783814 | Folic acid fortification: time for a concentrated effort. |
Q34281640 | Folic acid in early pregnancy: a public health success story |
Q22337184 | Folic acid in pregnancy and fetal outcomes |
Q35891873 | Folic acid in pregnancy and mortality from cancer and cardiovascular disease: further follow-up of the Aberdeen folic acid supplementation trial |
Q61816278 | Folic acid modifies the shape of epithelial cells during morphogenesis via a Folr1 and MLCK dependent mechanism |
Q53243710 | Folic acid prevents neural tube defects: international comparison of awareness among obstetricians/gynecologists and urologists. |
Q37645044 | Folic acid supplementation and preterm birth: results from observational studies |
Q33799905 | Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST). |
Q37431174 | Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI. |
Q35634260 | Folic acid supplementation in early pregnancy and asthma in children aged 6 years |
Q47157335 | Folic acid supplementation: more work is needed |
Q40568743 | Folic acid supplements and risk for oral clefts in the newborn: a population-based study |
Q44306116 | Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study |
Q43743052 | Folic acid supplements during pregnancy and risk of miscarriage |
Q37190519 | Folic acid supplements in pregnancy and severe language delay in children |
Q33754493 | Folic acid to reduce neonatal mortality from neural tube disorders |
Q36456712 | Folic acid: a public-health challenge |
Q34034910 | Folic acid: the opportunity that still exists; [comment]. |
Q37005664 | Food fortification and decline in the prevalence of neural tube defects: does public intervention reduce the socioeconomic gap in prevalence? |
Q88390986 | Formate rescues neural tube defects caused by mutations in Slc25a32 |
Q34621508 | Fortification of flour with folic acid. |
Q44414405 | Frequency of Down's syndrome and neural-tube defects in the same family |
Q40867836 | Functional variant in methionine synthase reductase intron-1 is associated with pleiotropic congenital malformations |
Q37246148 | Gene-nutrient interactions: importance of folic acid and vitamin B12 during early embryogenesis |
Q33732467 | Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women. |
Q37465331 | Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida |
Q38734243 | Genetic polymorphisms and folate status. |
Q55051367 | Genetic polymorphisms in the thioredoxin 2 (TXN2) gene and risk for spina bifida. |
Q48173288 | Genetic screening and functional analysis of CASP9 mutations in a Chinese cohort with neural tube defects. |
Q38135224 | Genetic studies of myelomeningocele |
Q34672452 | Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature |
Q34614564 | Genetics of homocysteine metabolism and associated disorders |
Q34309022 | Gene–environment interactions, folate metabolism and the embryonic nervous system |
Q27310655 | Genomic DNA hypomethylation is associated with neural tube defects induced by methotrexate inhibition of folate metabolism |
Q34098137 | Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age |
Q99551160 | Genomic profiling of bacterial and fungal communities and their predictive functionality during pulque fermentation by whole-genome shotgun sequencing |
Q34232715 | Geographical and ethnic distribution of single nucleotide polymorphisms within genes of the folate/homocysteine pathway metabolism |
Q39668918 | Geographical, Seasonal and Gender Differences in Folate Status among Chinese Adults |
Q33813708 | Getting married in China: pass the medical first |
Q24658586 | Global implementation of genomic medicine: We are not alone |
Q82718265 | Glutamate carboxypeptidase II gene polymorphisms and neural tube defects in a high-risk Chinese population |
Q37981222 | Has folate a role in the developing nervous system after birth and not just during embryogenesis and gestation? |
Q43040922 | Health impact in China of folate-biofortified rice |
Q53288039 | Health state preference scores of children with spina bifida and their caregivers. |
Q59807672 | High burden of neural tube defects in Tigray, Northern Ethiopia: Hospital-based study |
Q44947714 | High rates of neural tube defects in Ukraine |
Q37755146 | Homocysteine: biomarker or cause of adverse pregnancy outcome? |
Q40266279 | Household air pollution and personal exposure risk of polycyclic aromatic hydrocarbons among rural residents in Shanxi, China. |
Q33303922 | How well do blood folate concentrations predict dietary folate intakes in a sample of Canadian lactating women exposed to high levels of folate? An observational study |
Q46221198 | Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities |
Q40713440 | Hyperhomocysteinemia Is Associated with Vitamin B-12 Deficiency: A Cross-sectional Study in a Rural, Elderly Population of Shanxi China |
Q85112551 | Hypotension in pregnant women: a population-based case–control study of pregnancy complications and birth outcomes |
Q40480654 | Impact of Periconceptional Use of Nitrosatable Drugs on the Risk of Neural Tube Defects. |
Q43922478 | Impact of an educational seminar on high school students' knowledge of folic acid supplementation and its role in the prevention of birth defects. |
Q34291579 | Impact of folic acid fortification of flour on neural tube defects: a systematic review |
Q36961006 | Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial |
Q37027554 | Importance of folate-homocysteine homeostasis during early embryonic development |
Q43914415 | Improper supplementation habits of folic acid intake by Hungarian pregnant women: improper recommendations |
Q90168353 | Inadequate Folic Acid Intake Among Women Taking Antiepileptic Drugs During Pregnancy in Japan: A Cross-Sectional Study |
Q33710383 | Increasing prevalence, changes in diagnostic criteria, and nutritional risk factors for autism spectrum disorders |
Q34736750 | Inertia on folic acid fortification: public health malpractice |
Q44425788 | Influence of the antifolate drug Methotrexate on the development of murine neural tube defects and genomic instability |
Q45975878 | Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States. |
Q36779043 | Inositol for the prevention of neural tube defects: a pilot randomised controlled trial |
Q37543226 | Integration of risk and benefit analysis-the window of benefit as a new tool? |
Q40204079 | Interaction between the SLC19A1 gene and maternal first trimester fever on offspring neural tube defects |
Q33930503 | International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? |
Q43968063 | Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model |
Q38685268 | Is Depression Related to Low Folate Levels in People with Epilepsy? An Observational Study and Meta-analysis |
Q47634413 | Japanese couples' childbirth experiences in Michigan: implications for care |
Q64092153 | Knowledge and intake of folic acid among teachers of childbearing age in the State of Qatar: a cross-sectional study |
Q36771380 | Knowledge and use of folic acid for birth defect prevention among women of childbearing age in Shanghai, China: a prospective cross-sectional study. |
Q51121189 | Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis. |
Q38630270 | Large -scale wheat flour folic acid fortification program increases plasma folate levels among women of reproductive age in urban Tanzania |
Q37171834 | Levels of folate receptor autoantibodies in maternal and cord blood and risk of neural tube defects in a Chinese population |
Q51028439 | Limited risks of major congenital anomalies in children of mothers with coeliac disease: a population-based cohort study. |
Q37082622 | Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects |
Q40475833 | Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? |
Q39747545 | Low folic acid status and its association with anaemia in urban adolescent girls and women of childbearing age in Sri Lanka |
Q42959470 | Low folic acid supplement intake rate among women in northern China with a high-prevalence of neural tube defects, 2008. |
Q77160851 | Low maternal vitamin D and schizophrenia in offspring |
Q41696695 | MTHFD1 polymorphism as maternal risk for neural tube defects: a meta-analysis |
Q55241189 | MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial. |
Q64260106 | Macronutrient and Micronutrient Intake during Pregnancy: An Overview of Recent Evidence |
Q24680158 | Management of epilepsy in women |
Q37176531 | Maternal B vitamin status in pregnancy week 18 according to reported use of folic acid supplements |
Q42368215 | Maternal Prenatal Folic Acid Supplementation Programs Offspring Lipid Metabolism by Aberrant DNA Methylation in Hepatic ATGL and Adipose LPL in Rats |
Q92533479 | Maternal adherence to micronutrient supplementation before and during pregnancy in Northwest China: a large-scale population-based cross-sectional survey |
Q43433593 | Maternal body mass index and the association between folic acid supplements and neural tube defects |
Q35239518 | Maternal dietary uridine causes, and deoxyuridine prevents, neural tube closure defects in a mouse model of folate-responsive neural tube defects |
Q43406466 | Maternal early pregnancy body mass index and risk of preterm birth |
Q91523062 | Maternal folate levels during pregnancy and children's neuropsychological development at 2 years of age |
Q38590693 | Maternal folate status and obesity/insulin resistance in the offspring: a systematic review |
Q92008986 | Maternal folic acid supplementation and more prominent birth weight gain in twin birth compared with singleton birth: a cross-sectional study in northwest China |
Q101469852 | Maternal folic acid supplementation mediates the associations between maternal socioeconomic status and congenital heart diseases in offspring |
Q36116592 | Maternal food insecurity is associated with increased risk of certain birth defects |
Q91013876 | Maternal haemoglobin concentrations before and during pregnancy as determinants of the concentrations of children at 3-5 years of age: A large follow-up study |
Q40267901 | Maternal obesity, caesarean delivery and caesarean delivery on maternal request: a cohort analysis from China |
Q59806213 | Maternal periconceptional consumption of sprouted potato and risks of neural tube defects and orofacial clefts |
Q44771909 | Maternal severe stressful life events and risk of neural tube defects among rural Chinese |
Q28292615 | Maternal smoking during pregnancy and neural tube defects in offspring: a meta-analysis |
Q36019883 | Maternal tea consumption during early pregnancy and the risk of spina bifida |
Q39748857 | Maternal use of folic acid supplements and infant risk of neural tube defects in Norway 1999-2013. |
Q22336986 | Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification |
Q92250343 | Maximising benefits and minimising adverse effects of micronutrient interventions in low- and middle-income countries |
Q43852216 | Medication use during pregnancy and the risk of childhood cancer in the offspring |
Q41450860 | Mediterranean diet, folic acid, and neural tube defects |
Q33979992 | Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil |
Q33920719 | Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy |
Q42951688 | Methylenetetrahydrofolate reductase gene polymorphisms and neural tube defects epidemiology in the Slovak population |
Q35968243 | Micronutrient fortification of foods--rationale, application and impact |
Q37725925 | Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I--Folate, Vitamin B12, Vitamin B6. |
Q34421738 | Micronutrients in women's health and immune function |
Q36524564 | Modeling fortification of corn masa flour with folic acid: the potential impact on exceeding the tolerable upper intake level for folic acid, NHANES 2001-2008. |
Q64137743 | Modeling the impact of folic acid fortification and supplementation on red blood cell folate concentrations and predicted neural tube defect risk in the United States: have we reached optimal prevention? |
Q43742230 | Modelling the potential impact of population-wide periconceptional folate/multivitamin supplementation on multiple births |
Q37889824 | More folic acid, the five questions: why, who, when, how much, and how. |
Q37246176 | National Neural Tube Defects Prevention Program in China |
Q90454618 | National population-based estimates for major birth defects, 2010-2014 |
Q36174869 | Neighborhood Deprivation and Risk of Congenital Heart Defects, Neural Tube Defects and Orofacial Clefts: A Systematic Review and Meta-Analysis |
Q33745049 | Neonatal Mortality and Prevalence of Practices for Newborn Care in a Squatter Settlement of Karachi, Pakistan: A Cross-Sectional Study |
Q87405864 | Neural tube defects |
Q24617456 | Neural tube defects and folate: case far from closed |
Q35116653 | Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States |
Q36455973 | Neural tube defects and maternal intake of micronutrients related to one-carbon metabolism or antioxidant activity |
Q38068833 | Neural tube defects and their significance in clinical dentistry: a mini review |
Q35963045 | Neural tube defects in Costa Rica, 1987-2012: origins and development of birth defect surveillance and folic acid fortification |
Q46695753 | Neural tube defects in India--time for action |
Q35775893 | Neural tube defects in Latin America and the impact of fortification: a literature review |
Q47822638 | Neural tube defects in the Republic of Ireland in 2009-11. |
Q37236998 | Neural tube defects, folic acid and methylation |
Q39251514 | Neural tube defects: Risk factors and preventive measures. |
Q34914300 | Neural tube defects: prevalence, etiology and prevention |
Q33620909 | Neural tube defects: recent advances, unsolved questions, and controversies |
Q46332837 | Neurological congenital malformations in a tertiary hospital in south Brazil |
Q36201052 | New Perspective on Impact of Folic Acid Supplementation during Pregnancy on Neurodevelopment/Autism in the Offspring Children - A Systematic Review |
Q34121906 | New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? |
Q24337874 | Nonsyndromic cleft lip and palate: CRISPLD genes and the folate gene pathway connection |
Q37350105 | Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid |
Q28066331 | Nutrition, One-Carbon Metabolism and Neural Tube Defects: A Review |
Q43509516 | Nutritional status of the elderly in rural North China: a cross-sectional study |
Q45089709 | Obesity affects short-term folate pharmacokinetics in women of childbearing age. |
Q64125806 | One-Carbon Cofactor Intake and Risk of Neural Tube Defects Among Women Who Meet Folic Acid Recommendations: A Multicenter Case-Control Study |
Q34488750 | Oral cleft prevention program (OCPP). |
Q36435615 | Oral clefts and maternal biomarkers of folate-dependent one-carbon metabolism in Utah |
Q34221016 | Oral contraceptive use: impact on folate, vitamin B₆, and vitamin B₁₂ status |
Q47224386 | Oxidative Stress and Apoptosis in Benzo[a]pyrene-Induced Neural Tube Defects. |
Q55098084 | Paternal characteristics associated with maternal periconceptional use of folic acid supplementation. |
Q36486528 | Patterns of folic acid use in pregnant Saudi women and prevalence of neural tube defects - Results from a nested case-control study |
Q40940349 | Periconceptional Multivitamin Supplementation Containing Folic Acid and Sex Ratio at Birth in a Chinese Population: a Prospective Cohort Study |
Q36151451 | Periconceptional folate deficiency and implications in neural tube defects |
Q46850503 | Periconceptional folates and the prevention of orofacial clefts: role of dietary intakes in France |
Q40252166 | Periconceptional folic acid supplementation among pregnant women with epilepsy in a developing country: a retroprospective survey in China |
Q91843674 | Periconceptional folic acid supplementation and risk of parent-reported asthma in children at 4-6 years of age |
Q60045518 | Periconceptional folic acid supplementation and sex difference in prevention of neural tube defects and their subtypes in China: results from a large prospective cohort study |
Q34649183 | Periconceptional folic acid supplementation and the risk of preterm births in China: a large prospective cohort study |
Q37726461 | Periconceptional folic acid supplementation and vitamin B12 status in a cohort of Chinese early pregnancy women with the risk of adverse pregnancy outcomes. |
Q50707571 | Periconceptional folic acid use among women giving birth at Queen Mary Maternity Hospital in Dunedin |
Q44403303 | Periconceptional folic acid use and the prevalence of neural tube defects in The Netherlands |
Q60045169 | Periconceptional intake of folic acid among low-risk women in Canada: summary of a workshop aiming to align prenatal folic acid supplement composition with current expert guidelines |
Q40573287 | Periconceptional multivitamin folic acid use, dietary folate, total folate and risk of neural tube defects in South Carolina |
Q34091191 | Periconceptional nutrient intakes and risks of neural tube defects in California |
Q24235306 | Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects |
Q33907277 | Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. |
Q80104786 | Periconceptional use of folic acid in Shanxi Province of northern China |
Q44468328 | Periconceptional use of folic acid supplements in Oslo |
Q44803557 | Perinatal outcomes in native Chinese and Chinese-American women |
Q30391911 | Perspectives on the design and methodology of periconceptional nutrient supplementation trials |
Q37869124 | Pharmacogenetics of drug-induced birth defects: what is known so far? |
Q46445919 | Physical activity and risk of neural tube defects |
Q39877945 | Plasma folate status and dietary folate intake among Chinese women of childbearing age. |
Q36051521 | Polymorphisms in MTHFD1 Gene and Susceptibility to Neural Tube Defects: A Case-Control Study in a Chinese Han Population with Relatively Low Folate Levels |
Q23919547 | Polytomous logistic regression as a tool for exploring heterogeneity across birth defect subtypes: an example using anencephaly and spina bifida |
Q33969910 | Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model |
Q34155975 | Position of the American Dietetic Association: nutrition and lifestyle for a healthy pregnancy outcome |
Q34492216 | Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies |
Q39043967 | Pre-conceptional folic acid supplement use according to maternal country of birth |
Q46373561 | Pre-conceptional vitamin/folic acid supplementation 2007. |
Q46870954 | Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies |
Q93163907 | Preconception blood pressure and risk of gestational hypertension and preeclampsia: a large cohort study in China |
Q24811883 | Preconception care by family physicians and general practitioners in Japan |
Q27022466 | Preconception care: nutritional risks and interventions |
Q28397687 | Preconception serum 1,1,1-trichloro-2,2,bis(p-chlorophenyl)ethane and B-vitamin status: independent and joint effects on women's reproductive outcomes |
Q39852875 | Preconceptional folic acid supplement use in Lebanon |
Q46931062 | Preconceptional folic acid utilization in Israel: five years after the guidelines |
Q46663975 | Pregnancy and epilepsy. Retrospective analysis of 118 patients |
Q35236942 | Pregnancy, epilepsy, and anticonvulsants. |
Q64938443 | Pregnant women's use and attitude toward herbal, vitamin, and mineral supplements in an academic tertiary care center, Riyadh, Saudi Arabia. |
Q79249789 | Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America |
Q34734164 | Prenatal famine exposure and cognition at age 59 years |
Q34368566 | Prenatal folic acid and risk of asthma in children: a systematic review and meta-analysis |
Q46301120 | Prenatal folic acid use associated with decreased risk of myelomeningocele: A case-control study offers further support for folic acid fortification in Bangladesh |
Q37673254 | Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects? |
Q47303918 | Prepregnancy body mass index and gestational weight gain with the outcome of pregnancy: a 13-year study of 292,568 cases in China |
Q37802813 | Prepregnancy obesity: a complex risk factor for selected birth defects |
Q39907570 | Prevalence and predictors of periconceptional folic acid uptake--prospective cohort study in an Irish urban obstetric population. |
Q38409671 | Prevalence and trend of neural tube defects in five counties in Shanxi province of Northern China, 2000 to 2014. |
Q36188645 | Prevalence of Congenital Anomalies in an Indian Maternal Cohort: Healthcare, Prevention, and Surveillance Implications |
Q38808705 | Prevalence of Neural Tube Defects and the Impact of Prenatal Diagnosis in Three Districts of Beijing, China. |
Q44476904 | Prevalence of anaemia among pregnant women in South-East China, 1993-2005. |
Q40611002 | Prevalence of autism spectrum disorders in China |
Q28386310 | Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis |
Q44253009 | Preventing folate-related neural tube defects: Problem solved, or not? |
Q37828099 | Prevention of chronic kidney disease in spina bifida |
Q33712654 | Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands |
Q44157484 | Prevention of fumonisin B1-induced neural tube defects by folic acid |
Q38135233 | Prevention of myelomeningocele: African perspectives |
Q35922009 | Prevention of neural tube defects with folic acid: The Chinese experience |
Q27001700 | Prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins? |
Q36664872 | Prevention of oro-facial clefts in developing world. |
Q33949484 | Primary prevention of neural-tube defects and some other congenital abnormalities by folic acid and multivitamins: history, missed opportunity and tasks |
Q34111808 | Primary prevention of neural-tube defects and some other major congenital abnormalities: recommendations for the appropriate use of folic acid during pregnancy |
Q75325631 | Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects |
Q44332037 | Prophylaxis of neural tube defects with folic acid in pregnant women from a health district |
Q64136817 | Prospective investigation of folic acid supplements before and during early pregnancy and paediatric and adult cancers in the Chinese children and families cohort: a pilot study in a sample of rural and urban families |
Q92977384 | Proteins as Nano-Carriers for Bioactive Compounds. The Case of 7S and 11S Soy Globulins and Folic Acid Complexation |
Q37246164 | Public health significance of supplementation or fortification of grain products with folic acid |
Q34469951 | Quantifying the effect of folic acid |
Q35036553 | RFC-1 80G>A polymorphism in case-mother/control-mother dyads is associated with risk of nephroblastoma and neuroblastoma |
Q85358088 | Raltitrexed's effect on the development of neural tube defects in mice is associated with DNA damage, apoptosis, and proliferation |
Q37099092 | Red Blood Cell Folate Insufficiency among nonpregnant Women of Childbearing age in Guatemala 2009 to 2010: Prevalence and predicted Neural Tube Defects risk |
Q24795119 | Reduced-folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart |
Q52038036 | Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. |
Q35311051 | Replication and exploratory analysis of 24 candidate risk polymorphisms for neural tube defects |
Q36298328 | Research goals for folate and related B vitamin in Europe. |
Q36827453 | Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S. |
Q36552218 | Risk factors associated with birth defects at a tertiary care center in Pakistan |
Q45896680 | Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan |
Q37175307 | Risk of spina bifida and maternal cigarette, alcohol, and coffee use during the first month of pregnancy |
Q35579910 | Role of Folate in Colon Cancer Development and Progression |
Q43964920 | Role of methotrexate exposure in apoptosis and proliferation during early neurulation |
Q36834927 | Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment |
Q40339423 | Scorecard for spina bifida research, prevention, and policy - A development process |
Q91581194 | Scorecard for spina bifida research, prevention, and policy: Score analysis by Human Development Index and WHO region |
Q79409095 | Screening for novel PAX3 polymorphisms and risks of spina bifida |
Q34768953 | Secular trends in age at menarche among women born between 1955 and 1985 in Southeastern China |
Q34051666 | Secular trends of macrosomia in southeast China, 1994-2005. |
Q34976180 | Self-reported vitamin supplementation in early pregnancy and risk of miscarriage |
Q58576790 | Sex differences in the prevalence of neural tube defects and preventive effects of folic acid (FA) supplementation among five counties in northern China: results from a population-based birth defect surveillance programme |
Q88960538 | Simultaneous quantitation of folates, flavins and B6 metabolites in human plasma by LC-MS/MS assay: Applications in colorectal cancer |
Q37178343 | Six paths for the future of social epidemiology |
Q56168692 | Spina bifida |
Q44103087 | Spina bifida and folate-related genes: a study of gene-gene interactions. |
Q37208056 | Syndromes, disorders and maternal risk factors associated with neural tube defects (IV). |
Q61807791 | Systematic Review and Bayesian Meta-analysis of the Dose-response Relationship between Folic Acid Intake and Changes in Blood Folate Concentrations |
Q35127991 | Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established |
Q44568739 | The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months |
Q55251185 | The Chinese Children and Families Cohort Study: The Nutrition, Physical Activity, and Ultraviolet Radiation Data Collection. |
Q35121188 | The Epidemiology of Adverse Pregnancy Outcomes: An Overview |
Q55224872 | The Evolving Role of Multivitamin/Multimineral Supplement Use among Adults in the Age of Personalized Nutrition. |
Q36529100 | The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency |
Q56442748 | The March of Dimes and Polio |
Q39672820 | The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention |
Q33636280 | The N-methyl-d-aspartate receptor in heart development: a gene knockdown model using siRNA. |
Q37069404 | The Relationship between Folic Acid and Risk of Autism Spectrum Disorders |
Q61453869 | The Role of Oxidative Stress in the Pathomechanism of Congenital Malformations |
Q33357503 | The Use of Folic Acid for the Prevention of Neural Tube Defects and Other Congenital Anomalies |
Q37390954 | The association and significance of H3K27me3 and a folate metabolic gene ACat2 in neural tube defects |
Q34279928 | The association between cesarean delivery on maternal request and method of newborn feeding in China |
Q42655647 | The association between major birth defects and preterm birth |
Q86353904 | The association between periconceptional folic acid supplementation and congenital heart defects: a case-control study in China |
Q44287756 | The beneficial effect of folate-enriched egg on the folate and homocysteine levels in rats fed a folate- and choline-deficient diet |
Q36914843 | The continuing challenge of understanding, preventing, and treating neural tube defects. |
Q30518266 | The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex. |
Q33875758 | The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirths |
Q37196093 | The effect of inhibiting glycinamide ribonucleotide formyl transferase on the development of neural tube in mice |
Q38648696 | The effects of preconception interventions on improving reproductive health and pregnancy outcomes in primary care: A systematic review |
Q51983844 | The effects of prenatal use of folic acid and other dietary supplements on early child development. |
Q47612018 | The epidemiology of developmental disabilities in low-income countries |
Q36277582 | The fetal origins of the metabolic syndrome: can we intervene? |
Q81297011 | The global challenges of birth defects and disabilities |
Q48170834 | The human T locus and spina bifida risk |
Q24534785 | The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter |
Q37707826 | The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida |
Q36472226 | The impact of prenatal diagnosis on neural tube defect (NTD) pregnancy versus birth incidence in British Columbia |
Q35309398 | The impact of spina bifida on caregivers |
Q37057724 | The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders |
Q57710605 | The nutrition transition in the Republic of Ireland: trends in energy and nutrient supply from 1961 to 2007 using Food and Agriculture Organization food balance sheets |
Q55021258 | The pharmacokinetic advantage of 5-methyltetrahydrofolate for minimization of the risk for birth defects. |
Q35114623 | The prevalence and nature of the use of preconception services by women with chronic health conditions: an integrative review. |
Q35063481 | The prevention of congenital anomalies with periconceptional folic acid supplementation |
Q24791130 | The primary prevention of birth defects: Multivitamins or folic acid? |
Q42700768 | The recurrence risk of neural tube defects (NTDs) in a population with high prevalence of NTDs in northern China. |
Q44806713 | The role of the folic acid to the prevention of orofacial cleft: an epidemiological study. |
Q37399043 | The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. |
Q34497850 | The status of vitamin B12 and folate among Chinese women: a population-based cross-sectional study in northwest China |
Q43819085 | The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study |
Q46666425 | Theory of planned behavior and multivitamin supplement use in Caucasian college females |
Q56669805 | Total prevention of folic acid-preventable spina bifida and anencephaly would reduce child mortality in India: Implications in achieving Target 3.2 of the Sustainable Development Goals |
Q88732362 | Toward a National Birth Cohort Study in China |
Q40190742 | Trends and characteristics of fetal and neonatal mortality due to congenital anomalies, Colombia 1999-2008. |
Q36651303 | Trimethoprim Use prior to Pregnancy and the Risk of Congenital Malformation: A Register-Based Nationwide Cohort Study |
Q34301812 | Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study. |
Q35891727 | U.S. women of childbearing age who are at possible increased risk of a neural tube defect-affected pregnancy due to suboptimal red blood cell folate concentrations, National Health and Nutrition Examination Survey 2007 to 2012. |
Q84966912 | Unusual patterns of neural tube defects in a high risk region of northern China |
Q51858007 | Urinary tract anomalies associated with MTHFR gene polymorphism C677T in girls. |
Q57710612 | Use of FAO food balance sheets to estimate the potential ability of novel folate-enriched eggs to increase the folate supply in European Union countries |
Q43697546 | Use of folic acid and delivery outcome: a prospective registry study |
Q37438395 | Use of folic acid supplements in early pregnancy in relation to maternal plasma levels in week 18 of pregnancy |
Q39346669 | Using latent class cluster analysis to screen high risk clusters of birth defects between 2009 and 2013 in Northwest China |
Q43348310 | Utilization of folic acid and iron supplementation services by pregnant women attending an antenatal clinic at a regional referral hospital in Kenya |
Q50544182 | Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. |
Q64229545 | Variants identified in PTK7 associated with neural tube defects |
Q48239565 | Variants in MTHFR gene and neural tube defects susceptibility in China |
Q48681053 | Variants in maternal COMT and MTHFR genes and risk of neural tube defects in offspring |
Q43671845 | Weekly administration of folic acid and epidemiology of neural tube defects |
Q93170219 | Whole Genome Analyses of Chinese Population and De Novo Assembly of A Northern Han Genome |
Q37017005 | Will increasing folic acid in fortified grain products further reduce neural tube defects without causing harm?: consideration of the evidence |
Q59284218 | ¿Qué es una variable de confusión? |
Search more.